Stay updated on CTX110 in B-Cell Malignancies Clinical Trial

Sign up to get notified when there's something new on the CTX110 in B-Cell Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX110 in B-Cell Malignancies Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The CTX110 CARBON study record is available, describing its trial design, participant criteria, locations, and reported outcomes. It indicates the study is terminated and no longer seeking participants, with follow-up planned in another study.
    Difference
    68%
    Check dated 2026-11-08T01:36:34.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T20:38:57.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says some NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T20:37:45.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:14:43.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer's site revision identifier changed from v3.7.0 to v3.7.1. The page still displays a 403 error instead of the clinical study record.
    Difference
    0.2%
    Check dated 2026-10-10T22:06:15.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous detailed study content with a minimal error message. This reflects an access restriction rather than an update to the study data or page purpose.
    Difference
    19%
    Check dated 2026-09-19T22:25:16.000Z thumbnail image

Stay in the know with updates to CTX110 in B-Cell Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX110 in B-Cell Malignancies Clinical Trial page.